Medical Care
Global Prostate-specific Antigen (PSA) Testing Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 717
- Pages: 110
- Figures: 143
- Views: 1
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market is projected to grow from US$ 528.3 million in 2024 to US$ 628.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th
Report Covers:
This report presents an overview of global market for Prostate-specific Antigen (PSA) Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate-specific Antigen (PSA) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate-specific Antigen (PSA) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate-specific Antigen (PSA) Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate-specific Antigen (PSA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate-specific Antigen (PSA) Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Segment by Type
CLIA Method
ELISA Method
Segment by Application
Screening
Post-treatment Monitoring
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate-specific Antigen (PSA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-specific Antigen (PSA) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate-specific Antigen (PSA) Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market is projected to grow from US$ 528.3 million in 2024 to US$ 628.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th
Report Covers:
This report presents an overview of global market for Prostate-specific Antigen (PSA) Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate-specific Antigen (PSA) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate-specific Antigen (PSA) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate-specific Antigen (PSA) Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate-specific Antigen (PSA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate-specific Antigen (PSA) Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Segment by Type
CLIA Method
ELISA Method
Segment by Application
Screening
Post-treatment Monitoring
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate-specific Antigen (PSA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-specific Antigen (PSA) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate-specific Antigen (PSA) Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CLIA Method
1.2.3 ELISA Method
1.3 Market by Application
1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2019-2030)
2.2 Global Prostate-specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prostate-specific Antigen (PSA) Testing by Players
3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prostate-specific Antigen (PSA) Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2023
3.5 Global Key Players of Prostate-specific Antigen (PSA) Testing Head office and Area Served
3.6 Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
3.7 Global Key Players of Prostate-specific Antigen (PSA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
6.4.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
7.4.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
8.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type
8.2.1 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
8.2.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
8.2.3 China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Application
8.3.1 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
8.3.2 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
8.3.3 China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
9.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type
9.2.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
9.2.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
9.2.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
9.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application
9.3.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
9.3.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
9.3.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
9.4 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region
9.4.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024)
9.4.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.3.5 Bayer AG Recent Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.4.5 Siemens Healthcare Recent Developments
11.5 DiaSorin
11.5.1 DiaSorin Company Details
11.5.2 DiaSorin Business Overview
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.5.5 DiaSorin Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.6.5 Roche Recent Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.7.5 Beckman Coulter Recent Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.8.5 PerkinElmer Recent Developments
11.9 Tosoh
11.9.1 Tosoh Company Details
11.9.2 Tosoh Business Overview
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.9.5 Tosoh Recent Developments
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Details
11.10.2 Ortho Clinical Business Overview
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.10.5 Ortho Clinical Recent Developments
11.11 Fujirebio
11.11.1 Fujirebio Company Details
11.11.2 Fujirebio Business Overview
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.11.5 Fujirebio Recent Developments
11.12 Mediwatch
11.12.1 Mediwatch Company Details
11.12.2 Mediwatch Business Overview
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.12.5 Mediwatch Recent Developments
11.13 BodiTech
11.13.1 BodiTech Company Details
11.13.2 BodiTech Business Overview
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.13.5 BodiTech Recent Developments
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Details
11.14.2 Bristol-Myers Squibb Company Business Overview
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.14.5 Bristol-Myers Squibb Company Recent Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Details
11.15.2 GE Healthcare Business Overview
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.15.5 GE Healthcare Recent Developments
11.16 Endocare
11.16.1 Endocare Company Details
11.16.2 Endocare Business Overview
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.16.5 Endocare Recent Developments
11.17 Merck＆Co.
11.17.1 Merck＆Co. Company Details
11.17.2 Merck＆Co. Business Overview
11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.17.5 Merck＆Co. Recent Developments
11.18 Medtronic
11.18.1 Medtronic Company Details
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.18.5 Medtronic Recent Developments
11.19 Sanofi-Aventis SA
11.19.1 Sanofi-Aventis SA Company Details
11.19.2 Sanofi-Aventis SA Business Overview
11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.19.5 Sanofi-Aventis SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CLIA Method
1.2.3 ELISA Method
1.3 Market by Application
1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2019-2030)
2.2 Global Prostate-specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prostate-specific Antigen (PSA) Testing by Players
3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prostate-specific Antigen (PSA) Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2023
3.5 Global Key Players of Prostate-specific Antigen (PSA) Testing Head office and Area Served
3.6 Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
3.7 Global Key Players of Prostate-specific Antigen (PSA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
6.4.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
7.4.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
8.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type
8.2.1 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
8.2.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
8.2.3 China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Application
8.3.1 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
8.3.2 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
8.3.3 China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
9.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type
9.2.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
9.2.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
9.2.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
9.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application
9.3.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
9.3.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
9.3.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
9.4 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region
9.4.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024)
9.4.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.3.5 Bayer AG Recent Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.4.5 Siemens Healthcare Recent Developments
11.5 DiaSorin
11.5.1 DiaSorin Company Details
11.5.2 DiaSorin Business Overview
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.5.5 DiaSorin Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.6.5 Roche Recent Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.7.5 Beckman Coulter Recent Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.8.5 PerkinElmer Recent Developments
11.9 Tosoh
11.9.1 Tosoh Company Details
11.9.2 Tosoh Business Overview
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.9.5 Tosoh Recent Developments
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Details
11.10.2 Ortho Clinical Business Overview
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.10.5 Ortho Clinical Recent Developments
11.11 Fujirebio
11.11.1 Fujirebio Company Details
11.11.2 Fujirebio Business Overview
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.11.5 Fujirebio Recent Developments
11.12 Mediwatch
11.12.1 Mediwatch Company Details
11.12.2 Mediwatch Business Overview
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.12.5 Mediwatch Recent Developments
11.13 BodiTech
11.13.1 BodiTech Company Details
11.13.2 BodiTech Business Overview
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.13.5 BodiTech Recent Developments
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Details
11.14.2 Bristol-Myers Squibb Company Business Overview
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.14.5 Bristol-Myers Squibb Company Recent Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Details
11.15.2 GE Healthcare Business Overview
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.15.5 GE Healthcare Recent Developments
11.16 Endocare
11.16.1 Endocare Company Details
11.16.2 Endocare Business Overview
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.16.5 Endocare Recent Developments
11.17 Merck＆Co.
11.17.1 Merck＆Co. Company Details
11.17.2 Merck＆Co. Business Overview
11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.17.5 Merck＆Co. Recent Developments
11.18 Medtronic
11.18.1 Medtronic Company Details
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.18.5 Medtronic Recent Developments
11.19 Sanofi-Aventis SA
11.19.1 Sanofi-Aventis SA Company Details
11.19.2 Sanofi-Aventis SA Business Overview
11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.19.5 Sanofi-Aventis SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of CLIA Method
Table 3. Key Players of ELISA Method
Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2024)
Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2025-2030)
Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2019-2024)
Table 16. Global Top Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)
Table 17. Global Prostate-specific Antigen (PSA) Testing Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Prostate-specific Antigen (PSA) Testing, Headquarters and Area Served
Table 20. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
Table 21. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2019-2024)
Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2025-2030)
Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Prostate-specific Antigen (PSA) Testing Product
Table 66. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. Boston Scientific Corporation Company Details
Table 69. Boston Scientific Corporation Business Overview
Table 70. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
Table 71. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 72. Boston Scientific Corporation Recent Developments
Table 73. Bayer AG Company Details
Table 74. Bayer AG Business Overview
Table 75. Bayer AG Prostate-specific Antigen (PSA) Testing Product
Table 76. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 77. Bayer AG Recent Developments
Table 78. Siemens Healthcare Company Details
Table 79. Siemens Healthcare Business Overview
Table 80. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 81. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 82. Siemens Healthcare Recent Developments
Table 83. DiaSorin Company Details
Table 84. DiaSorin Business Overview
Table 85. DiaSorin Prostate-specific Antigen (PSA) Testing Product
Table 86. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 87. DiaSorin Recent Developments
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Prostate-specific Antigen (PSA) Testing Product
Table 91. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 92. Roche Recent Developments
Table 93. Beckman Coulter Company Details
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
Table 96. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 97. Beckman Coulter Recent Developments
Table 98. PerkinElmer Company Details
Table 99. PerkinElmer Business Overview
Table 100. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
Table 101. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 102. PerkinElmer Recent Developments
Table 103. Tosoh Company Details
Table 104. Tosoh Business Overview
Table 105. Tosoh Prostate-specific Antigen (PSA) Testing Product
Table 106. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 107. Tosoh Recent Developments
Table 108. Ortho Clinical Company Details
Table 109. Ortho Clinical Business Overview
Table 110. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
Table 111. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 112. Ortho Clinical Recent Developments
Table 113. Fujirebio Company Details
Table 114. Fujirebio Business Overview
Table 115. Fujirebio Prostate-specific Antigen (PSA) Testing Product
Table 116. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 117. Fujirebio Recent Developments
Table 118. Mediwatch Company Details
Table 119. Mediwatch Business Overview
Table 120. Mediwatch Prostate-specific Antigen (PSA) Testing Product
Table 121. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 122. Mediwatch Recent Developments
Table 123. BodiTech Company Details
Table 124. BodiTech Business Overview
Table 125. BodiTech Prostate-specific Antigen (PSA) Testing Product
Table 126. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 127. BodiTech Recent Developments
Table 128. Bristol-Myers Squibb Company Company Details
Table 129. Bristol-Myers Squibb Company Business Overview
Table 130. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
Table 131. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 132. Bristol-Myers Squibb Company Recent Developments
Table 133. GE Healthcare Company Details
Table 134. GE Healthcare Business Overview
Table 135. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 136. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 137. GE Healthcare Recent Developments
Table 138. Endocare Company Details
Table 139. Endocare Business Overview
Table 140. Endocare Prostate-specific Antigen (PSA) Testing Product
Table 141. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 142. Endocare Recent Developments
Table 143. Merck＆Co. Company Details
Table 144. Merck＆Co. Business Overview
Table 145. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product
Table 146. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 147. Merck＆Co. Recent Developments
Table 148. Medtronic Company Details
Table 149. Medtronic Business Overview
Table 150. Medtronic Prostate-specific Antigen (PSA) Testing Product
Table 151. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 152. Medtronic Recent Developments
Table 153. Sanofi-Aventis SA Company Details
Table 154. Sanofi-Aventis SA Business Overview
Table 155. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
Table 156. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 157. Sanofi-Aventis SA Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2023 VS 2030
Figure 3. CLIA Method Features
Figure 4. ELISA Method Features
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2023 VS 2030
Figure 7. Screening Case Studies
Figure 8. Post-treatment Monitoring Case Studies
Figure 9. Other Case Studies
Figure 10. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2023
Figure 15. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2023
Figure 17. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 19. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 20. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 21. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 25. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 26. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 27. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 35. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 36. Asia Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 38. Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 39. Asia Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2030)
Figure 40. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 50. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 57. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 58. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 59. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 60. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 61. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 62. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 63. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 64. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 65. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 66. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 67. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 68. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 70. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 71. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 72. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 73. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 74. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of CLIA Method
Table 3. Key Players of ELISA Method
Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2024)
Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2025-2030)
Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2019-2024)
Table 16. Global Top Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)
Table 17. Global Prostate-specific Antigen (PSA) Testing Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Prostate-specific Antigen (PSA) Testing, Headquarters and Area Served
Table 20. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
Table 21. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2019-2024)
Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2025-2030)
Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Prostate-specific Antigen (PSA) Testing Product
Table 66. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. Boston Scientific Corporation Company Details
Table 69. Boston Scientific Corporation Business Overview
Table 70. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
Table 71. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 72. Boston Scientific Corporation Recent Developments
Table 73. Bayer AG Company Details
Table 74. Bayer AG Business Overview
Table 75. Bayer AG Prostate-specific Antigen (PSA) Testing Product
Table 76. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 77. Bayer AG Recent Developments
Table 78. Siemens Healthcare Company Details
Table 79. Siemens Healthcare Business Overview
Table 80. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 81. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 82. Siemens Healthcare Recent Developments
Table 83. DiaSorin Company Details
Table 84. DiaSorin Business Overview
Table 85. DiaSorin Prostate-specific Antigen (PSA) Testing Product
Table 86. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 87. DiaSorin Recent Developments
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Prostate-specific Antigen (PSA) Testing Product
Table 91. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 92. Roche Recent Developments
Table 93. Beckman Coulter Company Details
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
Table 96. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 97. Beckman Coulter Recent Developments
Table 98. PerkinElmer Company Details
Table 99. PerkinElmer Business Overview
Table 100. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
Table 101. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 102. PerkinElmer Recent Developments
Table 103. Tosoh Company Details
Table 104. Tosoh Business Overview
Table 105. Tosoh Prostate-specific Antigen (PSA) Testing Product
Table 106. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 107. Tosoh Recent Developments
Table 108. Ortho Clinical Company Details
Table 109. Ortho Clinical Business Overview
Table 110. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
Table 111. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 112. Ortho Clinical Recent Developments
Table 113. Fujirebio Company Details
Table 114. Fujirebio Business Overview
Table 115. Fujirebio Prostate-specific Antigen (PSA) Testing Product
Table 116. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 117. Fujirebio Recent Developments
Table 118. Mediwatch Company Details
Table 119. Mediwatch Business Overview
Table 120. Mediwatch Prostate-specific Antigen (PSA) Testing Product
Table 121. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 122. Mediwatch Recent Developments
Table 123. BodiTech Company Details
Table 124. BodiTech Business Overview
Table 125. BodiTech Prostate-specific Antigen (PSA) Testing Product
Table 126. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 127. BodiTech Recent Developments
Table 128. Bristol-Myers Squibb Company Company Details
Table 129. Bristol-Myers Squibb Company Business Overview
Table 130. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
Table 131. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 132. Bristol-Myers Squibb Company Recent Developments
Table 133. GE Healthcare Company Details
Table 134. GE Healthcare Business Overview
Table 135. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 136. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 137. GE Healthcare Recent Developments
Table 138. Endocare Company Details
Table 139. Endocare Business Overview
Table 140. Endocare Prostate-specific Antigen (PSA) Testing Product
Table 141. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 142. Endocare Recent Developments
Table 143. Merck＆Co. Company Details
Table 144. Merck＆Co. Business Overview
Table 145. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product
Table 146. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 147. Merck＆Co. Recent Developments
Table 148. Medtronic Company Details
Table 149. Medtronic Business Overview
Table 150. Medtronic Prostate-specific Antigen (PSA) Testing Product
Table 151. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 152. Medtronic Recent Developments
Table 153. Sanofi-Aventis SA Company Details
Table 154. Sanofi-Aventis SA Business Overview
Table 155. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
Table 156. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)
Table 157. Sanofi-Aventis SA Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2023 VS 2030
Figure 3. CLIA Method Features
Figure 4. ELISA Method Features
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2023 VS 2030
Figure 7. Screening Case Studies
Figure 8. Post-treatment Monitoring Case Studies
Figure 9. Other Case Studies
Figure 10. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2023
Figure 15. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2023
Figure 17. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 19. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 20. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 21. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 25. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 26. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 27. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 35. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 36. Asia Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 38. Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 39. Asia Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2030)
Figure 40. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)
Figure 50. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 57. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 58. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 59. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 60. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 61. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 62. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 63. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 64. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 65. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 66. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 67. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 68. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 70. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 71. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 72. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 73. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 74. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232